Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

Pity the middle-aged men agonising over whether or not to be screened for prostate cancer. Last year, a US government panel said that family doctors should not offer men a blood test for prostate ...

Does prostate cancer screening save lives? The Cochrane, an influential group renowned for its gold-standard medical reviews, has previously addressed that question twice, and twice the answer was ‘no ...

The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty of men who do not have aggressive disease while sometimes missing cancers ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

Prostate cancer screening does not necessarily need to be performed every year. “If your PSA levels are very low, your ...

A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...